Literature DB >> 29636876

MiR-143-3p suppresses the progression of ovarian cancer.

Haijuan Shi1, Huimin Shen2, Juan Xu3, Shanshan Zhao2, Shuzhong Yao2, Nan Jiang2.   

Abstract

MicroRNAs (miRNAs) are a class of naturally occurring, small, non-coding RNAs that target protein-coding mRNAs at the post-transcriptional level and participate in various biological processes. Our previous studies suggested that miR-143-3p functions as a tumor suppressor and has a role in the progression of ovarian cancer, in part through the regulation of the tumor promoter. In this study, we found that the mRNA expression level of miR-143-3p was significantly decreased in ovarian cancer tissues, in comparison with normal ovarian tissues by high-throughput miRNA profiling and quantitative RT-PCR. Secondly, we indicated that the up-regulation of miR-143-3p in the ovarian cancer cell lines SKOV3, ES2, and OVCAR3 significantly reduced their proliferation, migration, and invasion. Furthermore, miR-143-3p inhibited the growth of ovarian tumors in vivo in a xenograft experiment. In addition, miR-143-3p down-regulated the expression of transforming growth factor (TGF)-β-activated kinase 1 (TAK1) in human ovarian cancer cells. Therefore, our study indicates that miR-143-3p inhibited the proliferation, migration, and invasion of ovarian cancer cells in vitro, as well as ovarian tumorigenesis in vivo. This inhibitory effect may target TAK1, suggesting a potential application of the miR-143-3p-TAK1 pathway in the clinical diagnosis and treatment of ovarian cancer.

Entities:  

Keywords:  MiR-143-3p; TAK1; migration; ovarian cancer; proliferation; xenograft

Year:  2018        PMID: 29636876      PMCID: PMC5883127     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  26 in total

Review 1.  Cancer of the ovary.

Authors:  Stephen A Cannistra
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

2.  microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.

Authors:  Hao Zhang; Xiaobing Cai; Yang Wang; Hao Tang; Daki Tong; Fang Ji
Journal:  Oncol Rep       Date:  2010-11       Impact factor: 3.906

Review 3.  Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.

Authors:  Elisa Araldi; Aranzazu Chamorro-Jorganes; Coen van Solingen; Carlos Fernandez-Hernando; Yajaira Suarez
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

4.  Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.

Authors:  Xiaoming Zhang; Ying Dong; Hongjuan Ti; Jing Zhao; Ying Wang; Ting Li; Bo Zhang
Journal:  Hum Pathol       Date:  2013-09-24       Impact factor: 3.466

5.  Ovarian cancer.

Authors:  Bryan T Hennessy; Robert L Coleman; Maurie Markman
Journal:  Lancet       Date:  2009-09-28       Impact factor: 79.321

6.  microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.

Authors:  Aditya Parikh; Christine Lee; Peronne Joseph; Sergio Marchini; Alessia Baccarini; Valentin Kolev; Chiara Romualdi; Robert Fruscio; Hardik Shah; Feng Wang; Gavriel Mullokandov; David Fishman; Maurizio D'Incalci; Jamal Rahaman; Tamara Kalir; Raymond W Redline; Brian D Brown; Goutham Narla; Analisa DiFeo
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

7.  miR-762 can negatively regulate menin in ovarian cancer.

Authors:  Rui Hou; Zhuo Yang; ShiZhuo Wang; DaMing Chu; Qifang Liu; Jia Liu; Luo Jiang
Journal:  Onco Targets Ther       Date:  2017-04-12       Impact factor: 4.147

8.  Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.

Authors:  Jie Li; Qiang Li; He Huang; Yinguang Li; Li Li; Wenhui Hou; Zeshan You
Journal:  Int J Oncol       Date:  2017-03-07       Impact factor: 5.650

9.  TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice.

Authors:  Minghui Tang; Xudong Wei; Yinshi Guo; Peter Breslin; Shubin Zhang; Shanshan Zhang; Wei Wei; Zhenbiao Xia; Manuel Diaz; Shizuo Akira; Jiwang Zhang
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

10.  TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.

Authors:  Shan Guan; Jiaxiong Lu; Yanling Zhao; Sarah E Woodfield; Huiyuan Zhang; Xin Xu; Yang Yu; Jing Zhao; Shayahati Bieerkehazhi; Haoqian Liang; Jianhua Yang; Fuchun Zhang; Surong Sun
Journal:  Oncotarget       Date:  2017-05-16
View more
  26 in total

1.  Long Non-coding RNA LINC01426 Contributes to the Malignant Behaviors of NSCLC Via Acting As a Sponge for miR-143-3p.

Authors:  Wei Liu; Panpan Si; Hanlin Fang; Guangyao Ning; Chen Lu; Yunlong Huang
Journal:  Biochem Genet       Date:  2022-05-31       Impact factor: 1.890

Review 2.  Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved.

Authors:  Claudia Main; Xinyue Chen; Min Zhao; Lawrence W Chamley; Qi Chen
Journal:  Endocrinology       Date:  2022-10-11       Impact factor: 5.051

3.  MAPK1 Is Regulated by LOC102188416/miR-143-3p Axis in Dairy Goat Mammary Epithelial Cells.

Authors:  Yue Zhang; Jie Zhou; Shuang Liu; Zhibin Ji
Journal:  Genes (Basel)       Date:  2022-06-03       Impact factor: 4.141

4.  microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.

Authors:  Shan Pan; Mengyu Li; Haibo Yu; Zhiguo Xie; Xia Li; Xianlan Duan; Gan Huang; Zhiguang Zhou
Journal:  Acta Diabetol       Date:  2020-08-20       Impact factor: 4.280

5.  Inhibition of microRNA-143-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting FSTL1.

Authors:  Shunda Wang; Zhenguo Liu
Journal:  Neuromolecular Med       Date:  2021-03-11       Impact factor: 3.843

6.  Modulation in the microRNA repertoire is responsible for the stage-specific effects of Akt suppression on murine neuroendocrine prostate cancer.

Authors:  Abdulrahman Alwhaibi; Fei Gao; Sandeep Artham; Bernard M Hsia; Ashis Mondal; Ravindra Kolhe; Payaningal R Somanath
Journal:  Heliyon       Date:  2018-09-17

7.  MicroRNA-143-3p suppresses tumorigenesis by targeting catenin-δ1 in colorectal cancer.

Authors:  Xiaohua Ding; Jiying Du; Kai Mao; Xiaoyu Wang; Yuange Ding; Fanping Wang
Journal:  Onco Targets Ther       Date:  2019-05-01       Impact factor: 4.147

8.  Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p.

Authors:  Xiao Yu; Lei Hu; Suoyuan Li; Jun Shen; Donglai Wang; Renjie Xu; Huilin Yang
Journal:  Cell Death Dis       Date:  2019-03-25       Impact factor: 8.469

9.  Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis.

Authors:  Peisen Zhang; Hefan He; Yuyan Bai; Weifeng Liu; Lirong Huang
Journal:  Anticancer Drugs       Date:  2020-08       Impact factor: 2.389

10.  Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.

Authors:  Wei Gao; Chunming Zhang; Wenqi Li; Huizheng Li; Jiangwei Sang; Qinli Zhao; Yunfeng Bo; Hongjie Luo; Xiwang Zheng; Yan Lu; Yong Shi; Dongli Yang; Ruiping Zhang; Zhenyu Li; Jiajia Cui; Yuliang Zhang; Min Niu; Jun Li; Zhongqiang Wu; Huina Guo; Caixia Xiang; Juan Wang; Juan Hou; Lu Zhang; Rick F Thorne; Yongping Cui; Yongyan Wu; Shuxin Wen; Binquan Wang
Journal:  Mol Ther       Date:  2018-09-27       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.